Anjarium Biosciences

Anjarium Biosciences

Anjarium Biosciences is a pre-clinical biotechnology company founded in 2016 and based in Wädenswil, Switzerland, that has a bioinspired therapeutic delivery platform based on engineered exosomes for delivery of medicines for a broad range of severe diseases.

Anjarium Biosciences AG is a biotechnology company headquartered in Wädenswil, Switzerland that was founded in 2016 by Joël de Beer. The company aims to mimic native intercellular communication pathways in order to generate a novel class of bioinspired nanomedicines to deliver therapeutics precisely, efficiently and safely deliver to several disease targets throughout the body.

The Hybridosome platform is a proprietary engineering approach that transforms extracellular vesicles from natural cell to cell molecular message carriers to drug carriers by the addition of therapeutic and diagnostic cargoes into the lumen and modifications to the vesicle surface for added specificity and better biodistribution.

Timeline

2016

Anjarium Biosciences was founded.

People

Name
Role
LinkedIn

Jacqueline Ebneter

Scientist

Benjamin Peschke

Howard Riezman

Scientific Advisor

Nicolas Meier

Further reading

Title
Author
Link
Type
Date

Exosomes, nature's drug delivery fleet

Ryan Cross

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.